Victory Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,568
Closed -$1.78M 2827
2021
Q4
$1.78M Buy
+6,568
New +$2.22M ﹤0.01% 1593
2021
Q3
Sell
-6,463
Closed -$2.22M 2864
2021
Q2
$2.22M Sell
6,463
-57
-0.9% -$18.9K ﹤0.01% 1602
2021
Q1
$2.27M Buy
6,520
+944
+17% +$313K ﹤0.01% 1612
2020
Q4
$1.44M Sell
5,576
-6,154
-52% -$1.69M ﹤0.01% 1623
2020
Q3
$3.36M Sell
11,730
-400
-3% -$94K ﹤0.01% 1288
2020
Q2
$2.29M Sell
12,130
-67,156
-85% -$10.9M ﹤0.01% 1389
2020
Q1
$9.76M Buy
79,286
+38,130
+93% +$5.96M 0.01% 1092
2019
Q4
$6.82M Sell
41,156
-51,992
-56% -$8.64M 0.01% 1113
2019
Q3
$11.4M Buy
93,148
+54,598
+142% +$7.25M 0.01% 944
2019
Q2
$4.78M Sell
38,550
-210,680
-85% -$26.7M 0.01% 927
2019
Q1
$32.9M Buy
249,230
+24,350
+11% +$3.29M 0.07% 415
2018
Q4
$31.5M Buy
224,880
+66,950
+42% +$8.88M 0.08% 408
2018
Q3
$27.2M Sell
157,930
-690
-0.4% -$116K 0.06% 528
2018
Q2
$24.4M Buy
+158,620
New +$28.3M 0.05% 546
2017
Q1
Sell
-28,090
Closed -$853K 1872
2016
Q4
$853K Buy
+28,090
New +$883K ﹤0.01% 1170

Other funds holding ONC

Victory Capital Management's ONC Position: Q1 2022 in Review

Victory Capital Management sold out of BeOne Medicines Ltd (ONC) in Q1 2022, closing a stake of 6,568 shares — an estimated $1.78M sold.

Victory Capital Management first reported a position in ONC in Q4 2016 and held it in 15 quarters. The position peaked at $32.9M in Q1 2019. 238 funds tracked by Wall St. Rank hold ONC as of Q1 2022.

  • Victory Capital Management reported no remaining BeOne Medicines Ltd position as of Q1 2022 after selling out during the quarter.
  • Victory Capital Management sold 6,568 BeOne Medicines Ltd shares in Q1 2022, an estimated $1.78M.
  • Victory Capital Management first reported a position in BeOne Medicines Ltd in Q4 2016 and held it in 15 quarters.
  • Victory Capital Management's BeOne Medicines Ltd position peaked at $32.9M in Q1 2019.
  • 238 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2022.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.